Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006Archived
The authors analyzed data from hospital admissions and enhanced mumps surveillance to assess mumps complications during the largest mumps outbreak in England and Wales, 2004–2005, and their association with mumps vaccination. When compared with non-outbreak periods, the outbreak was associated with a clear increase in hospitalized patients with orchitis, meningitis and pancreatitis. Routine mumps surveillance and hospital data showed that 6.1% of mumps patients were hospitalized, 4.4% had orchitis, 0.35% meningitis and 0.33% pancreatitis.
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008Archived
In this study, the authors have combined a household method and a school study design to assess VE against mumps as well as VE against mumps infectiousness by comparing secondary attack rates in households of vaccinated and unvaccinated cases.
Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type BArchived
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.
Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?Archived
Despite long-standing mumps vaccination programmes with high coverage in Europe, a majority of the countries analysed have in recent years experienced mumps outbreaks
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
Mumps: Burden of disease in FranceArchived
Mumps is not a notifiable disease in France, and this study provides useful information by combining different data sources. The current incidence of mumps is somewhat higher than the average European (9 versus 3.2 per 100 000 per year) and authors sugges
ECDC to coordinate EUVAC.NET, the European surveillance network for numerous vaccine-preventable diseasesArchived
Starting 15 September 2011, ECDC will be coordinating the former EUVAC.NET network. It is a surveillance network covering measles, mumps, rubella, congenital rubella, pertussis and varicella EU Member States and three countries of the European Economic Area. Data will be hosted by the European Surveillance System (TESSy) at ECDC.
ECDC editorial emphasises doctors’ decisive role in helping eliminate measles, rubella in EUArchived
In an editorial in the scientific journal Eurosurveillance, ECDC noted that, based on numerous studies, paediatricians, family practitioners and nurses form the backbone of each national immunisation programme in the EU.